16:08 IST
NSE
Results Update
Windlas Biotech Results Update
Windlas Biotech reported Q1 FY27 revenue of Rs 248 crore, an 18% YoY growth. The release highlights an adjusted EBITDA of Rs 34 crore and PAT of Rs 25 crore.
Windlas Biotech Ltd
- Share price
- ₹1,022.00
- Market cap
- ₹2,145 Cr
- Revenue (annual)
- ₹904.1 Cr
- Net profit (annual)
- ₹66.44 Cr
- P/E (TTM)
- 32.3×Sector 47.3×
- Promoter holding
- 63.31%+1.41% QoQ
- FII holding
- 2.04%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Merger & Restructuring 10Earnings Call 4Financial Results 3Results Update 2Management Change 2Annual General Meeting 2Other Announcement 1Employee Stock Options 1Dividend 1Debt & Borrowing 1Credit Rating 1Board Meeting Outcome 1Board Meeting Date 1Annual Report 1Adverse Business Impact 1
Time
2 announcements with these filters
17:34 IST
NSE
Results Update
Windlas Biotech Results Update
Windlas Biotech reported record FY26 revenue of ₹904 Crore, representing 19% year-on-year growth. Adjusted PAT rose 31% to ₹83 Crore, reflecting strong operational performance.
- Value
- ₹904.0 Cr